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Low prevalence of patellar tendon abnormality and low
incidence of patellar tendinopathy in female collegiate
volleyball players
Marcey Keefer Hutchisona, Christopher Pattersonb, Tyler Cuddeforda, Robert Dudleyb,
Eric Sorensonb and Jason Brumitta
aSchool of Physical Therapy, George Fox University, Newberg, OR, USA; bAzusa Pacific University, Azusa,
CA, USA
ABSTRACT
The prevalence of patellar tendinopathy has been reported to be as
high as 50% in elite male volleyball (VB) players; however, the rate
of injury in female collegiate VB athletes is unknown. The purpose
of this study was to 1) identify the prevalence of ultrasonographic
evidence of patellar tendon abnormality at the start of the presea-
son in female collegiate VB players; 2) report the incidence of
tendinopathy during the season; and 3) determine if the preseason
presence of tendon abnormality is associated with onset of disease.
One hundred and six female collegiate VB players had both patellar
tendons imaged. Incidence of patellar tendinopathy was tracked
during the course of the 4-month season. Twenty-two athletes
presented with ultrasonographic evidence of patellar tendon
abnormality in at least one knee at the start of the preseason. The
incidence of time-loss patellar tendinopathy was 0.26 (95% CI: 0.04,
0.85) per 1000 athletic exposures. This study was unable to deter-
mine if preseason presence of tendon abnormality was associated
with a greater risk of tendinopathy due to power. The prevalence of
tendon abnormality in the preseason and the incidence of patellar
tendinopathy in female collegiate VB players are lower than that
observed in other populations.
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Patellar tendinopathy is an overuse injury marked by histopathological changes in the
portion of the tendon between the inferior pole of the patella and its insertion on the tibial
tubercle (Cook, Khan, Kiss, Purdam, & Griffiths, 2001a; Gisslen & Alfredson, 2005; Malliaras,
Cook, Purdam, & Rio, 2015; Mendonca et al., 2016; Peers & Lysens, 2005). Patellar tendino-
pathy, commonly referred to as jumper’s knee, is primarily experienced by athletes [age
range 14–30s; Note: Lian, Engebretsen, and Bahr (2005) reported tendinopathy in male
volleyball (VB) athletes with amean age of 26.8 ± 4.2 years] especially thosewho play VB and
basketball (Cook, Khan, Kiss, & Griffiths, 2000b; Cook, Khan, Kiss, Purdam, & Griffiths, 2000a;
Gisslen & Alfredson, 2005; Ito, Iwamoto, Azuma, & Matsumoto, 2014; Janssen, van der Worp,
CONTACT Jason Brumitt jbrumitt@georgefox.edu School of Physical Therapy, George Fox University,
414 N. Meridian St, Newberg, OR 97132, USA
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Hensing, & Zwerver, 2018; Lian et al., 2005; Witvrouw, Bellemans, Lysens, Danneels, &
Cambier, 2001). Prevalence of patellar tendinopathy in VB players has been reported
between 14.4% in Dutch community-based clubs or student teams (mean age 22.9 y ±
2.7) to over 50% in high-level male volleyball players (elite division players from Norwegian
teams; age range not provided) (Lian et al., 2005; Lian, Holen, Engebretsen, & Bahr, 1996).
In the United States, VB is a popular sport with over 27,000 women competing at the
collegiate level (O’Rourke, 2018). Incidence of injury in women’s VB at the collegiate level
has been reported for many common conditions; however, specific rates for patellar
tendinopathy have not been reported (Agel, Palmieri-Smith, Dick, Wojtys, & Marshall,
2007). Reported rates for “patella or patella tendon injury” range from 0.10 (95% CI: 0.07,
0.13) per 1000 athletic exposures (AE) during games to 0.15 (95% CI: 0.13, 0.17) during
practices (Agel et al., 2007). The prevalence of this condition in female collegiate volleyball
players is also unknown. This condition is challenging to treat with many athletes
experiencing loss of time from sport and/or having to retire prematurely from competi-
tion (Cook et al., 1997; Kettunen, Kvist, Alanen, & Kujala, 2002).
Identifying athletes at risk for developing patellar tendinopathy is warranted. In the
United States, there are several levels of competition at the collegiate level [e.g. National
Collegiate Athletic Association (NCAA) and National Association of Intercollegiate
Athletics (NAIA)]. Most athletes, except for those competing at the NCAA Division I level
report to their team in August after having been off-campus for the summer months.
Coaches and sports medicine professionals have a limited number of weeks to prepare
their athletes for their first competition (National Collegiate Athletic Association, 2019).
Screening athletes when they return back to campus may help identify athletes at risk for
injury. Diagnostic ultrasound imaging of the patellar tendon may be used as a screening
tool to identify athletes who present with a patellar tendon abnormality (Figure 1(a,b)).
The presence of a patellar tendon abnormality is not always associated with symptoms;
however, there is evidence that the presence of an abnormality increases the risk of
developing symptomatic patellar tendinopathy (Cook et al., 2000a). Cook et al. reported
a 4.2 times greater risk of elite basketball players (age range 14–18 y) developing
symptoms when they presented at baseline testing with an asymptomatic patellar tendon
abnormality (i.e., presence of a hypoechoic region) (Cook et al., 2000a). Subsequent
studies supported the aforementioned association between symptom onset and tendon
imaging at the start of the season (Gisslen, Gyulai, Nordstrom, & Alfredson, 2007; Visnes,
Tegnander, & Bahr, 2015). Visnes et al. (2015) reported the presence of a hypoechoic
region in an asymptomatic male or female elite teenage VB at baseline was associated
with a 3.3 times greater risk of developing patellar tendinopathy. The risk of developing
patellar tendinopathy was low in junior VB players (n = 22; mean age 16 y) who started the
season with normal clinical and diagnostic ultrasound findings (Gisslen et al., 2007).
The prevalence of patellar tendon abnormality is unknown in female collegiate VB
players. Also, unknown is if the presence of a tendon abnormality increases the risk of
one developing symptomatic patellar tendinopathy. There are three purposes to this study.
The first purpose of this study is to identify the prevalence of patellar tendon abnormality in
a population of female collegiate VB athletes at the start of the preseason. It was hypothe-
sized that these characteristics would be associated with a greater odds of having patellar
tendon abnormality at the start of the preseason: older age, taller/heavier/higher body
mass index (BMI), positions that require more jumping (e.g., outside hitter, middle blocker,
opposite hitter), athletes who devoted less time to off-season training, starters, and athletes
who played for institutions that offer athletic scholarships. The second purpose of this study
was to report the incidence density of patellar tendinopathy in this population. It was
hypothesized that female collegiate VB players would have an incidence of patellar tendi-
nopathy lower than 0.10 per 1000 AEs. The third purpose of this study was to determine if
the preseason presence of a patellar tendon abnormality is associated with a greater risk of
developing a diagnosis of patellar tendinopathy resulting in time-loss from sport.
Methods
A total of 106 female collegiate VB players (mean age 19.3 ± 1.1 years) representing 7
teams participated in this study. Teams were recruited from the Portland, OR and the
Figure 1. A) Hypoechoic region in a right patellar tendon from an 18-year-old national collegiate
athletic association division III volleyball player (longitudinal view). B) Cross-sectional view depicting
hypoechoic region.
Azusa, CA regions. The population sample consisted of VB players representing National
Collegiate Athletic Association (NCAA) D II (n = 32), NCAA D III (n = 49), and National
Association of Intercollegiate Athletes (NAIA) (n = 25) levels of competition. An athlete
was excluded from study participation if she was restricted from sport participation by the
team physician or the team’s certified athletic trainer due to injury, or was unable to
participate fully in practice, or was unable to complete a drop vertical jump from
30.48 cm, or was under the age of 18 at the time of testing. The 30.48 cm drop vertical
jump was included in the preseason testing battery as a part of a larger study. The
Institutional Review Boards of George Fox University (Newberg, OR) and Azusa Pacific
University (Azusa, CA) approved this study. Informed consent was collected from each
subject prior to study participation.
Testing protocol
Demographic information, anthropometric measures, and diagnostic ultrasound imaging
were collected during the athletes’ off-season period during the week prior to the official
start of their collegiate preseason. Demographic information was collected from each
athlete prior to imaging. Age was obtained from the athlete when she completed the
informed consent. Athletes reported the average time devoted per week for the 6-week
period prior to the start of the official preseason for the following training categories:
weight lifting, plyometric training, and scrimmaging. Height was collected using a cloth
tape affixed to a wall. Weight was collected when the athlete stood on a force plate (BP
600600 force plate, ATMI, Watertown, MA). BMI was calculated from height and weight
measures (BMI = kg/m2). Player position and starter/non-starter status were determined
by reviewing each team’s roster and season statistics.
Diagnostic ultrasound protocol
Ultrasonography (US) was performed by two researchers at George Fox University
(MKH: 27 years of clinical experience and 6 years of US experience; TC: 26 years of
clinical experience and 6 years of US experience) and one researcher at Azusa Pacific
University (CP: 13 years of clinical experience and 3 years of US experience). Inter-
rater reliability between different sonographers for collecting diagnostic ultrasound
images for the patellar tendon has proven to be excellent (Black, Cook, Kiss, & Smith,
2004; Del Bano-Aledo et al., 2017; Gellhorn & Carlson, 2013).
Athletes were positioned in supine on a treatment plinth with knees flexed to approxi-
mately 110 degrees. Four ultrasound images, a longitudinal view and three transverse
views were captured for each of the athlete’s patellar tendons. For the longitudinal view,
the captured image consisted of the tendon from the distal pole of patella to its insertion
at the tibial tuberosity. Transverse views were captured at the proximal (near the apex of
the patella) and distal insertion (near the tibial tuberosity) points, and midpoint between
these structures (a total of three images per tendon). Affinity 50G ultrasound machine
(Phillips Healthcare; Andover, MA) fitted with a 50 mm linear array probe (53 Hz) was used
at a depth of 2.5 cm for all images.
All ultrasound images were reviewed for the presence of patellar tendon abnormality
by MKH. MKH has previously reported a kappa statistic of 0.828 when evaluating patellar
tendons (Keefer Hutchison, Houck, Cuddeford, Dorociak, & Brumitt, 2019). A tendon was
identified as having a patellar tendon abnormality based on the presence of a hypoechoic
region (Figure 2). Individuals diagnosed with patellar tendinopathy frequently demon-
strate tendon abnormality in the form of a hypoechoic region and a thickened tendon.
None of the athletes at the start of the study were classified as having patellar tendino-
pathy. Rather, imaging was performed to identify abnormality, in particular, a hypoechoic
region, and to evaluate this finding as a potential risk factor for the onset of symptoms
during the season. The discussion section will discuss why tendon thickening was not
evaluated as a risk factor. Individuals were categorized as either having patellar tendon
abnormality in the right patellar tendon only, tendon abnormality in the left patellar
tendon only, tendon abnormality in both patellar tendons, or as having no presence of
patellar tendon abnormality in either tendon.
Injury Surveillance
Injury information and athletic exposures were collected from each team’s athletic
trainer on a weekly basis over the course of the 4-month season. The athletic trainers
reported the number of athletes participating in each event (i.e., practice or game) and
each injury resulting in time-loss. Athletic trainers were instructed to diagnose an athlete
with patellar tendinopathy if she presented with complaints of pain to the patellar tendon
during jumping or landing during sport, had pain with palpation to the patellar tendon,
and pain during a single-leg squat (Cook et al., 2000a; Malliaras et al., 2015; Ramos et al.,
2009; Visnes et al., 2015). For this study, only athletes diagnosed with patellar tendino-
pathy resulting from a noncontact mechanism were analysed.
Statistical analysis
An a priori sample size estimation was calculated using the proportions of individuals who
had developed patellar tendinopathy reported in Cook et al. (2000a). In that study, 30% of
athletes with asymptomatic patellar tendon abnormality (i.e., presence of a hypoechoic
Figure 2. A) Hypoechoic region in a left patellar tendon from an 18-year-old national collegiate
athletic association division III volleyball player (longitudinal view).
region) developed patellar tendinopathy whereas only 7% had developed in the control
group. For the prospective cohort component of this study the alpha level was set at 0.05,
power of 0.80, and using the aforementioned proportions a sample size of 90 subjects was
estimated.
Descriptive statistics (mean ± SD) were calculated for athlete’s age, height, weight,
BMI, and off-season training habits. Comparisons between VB players for demo-
graphic measures and reported off-season training habits were calculated by per-
forming independent t-tests. An athlete was categorized as having a patellar tendon
abnormality if she had sonographic evidence (i.e., a hypoechoic region) of tendon
abnormality. Logistic regression was performed to calculate prevalence odds ratios
(OR) for potential risk factors. Ten risk factors analysed in this study were: age,
height, weight, BMI, player position (e.g., jumping dominant positions: outside hitter
[OH], middle blocker [MB], opposite side hitter [OPP] vs. setter [S], libero [L], defen-
sive specialist [DS]), starter status, level of competition (programs that can offer
athletic scholarships: NCAA D II and NAIA vs. NCAA DIII), and the three off-season
training categories: weight lifting, plyometric training, and scrimmaging. Each factor
was dichotomized into an “at risk” and a “lesser risk” (i.e., reference) group. Receiver
operator characteristic (ROC) curves were constructed for each continuous variable;
however, none of the ROC curves depicted a potential cut-off score that maximize
sensitivity and specificity. Age was dichotomized based on mean scores from this
sample: the reference group consisted of athletes 19 years or younger whereas the at
risk group consisted of athletes 20 years of age and older. Taller, heavier, and
athletes with a larger BMI were categorized as at risk whereas shorter, lighter, and
normal weight (BMI) athletes served as the reference groups. Prior reports have
suggested that age, weight, and BMI may be risk factors for tendinopathy (Crossley
et al., 2007; Franeschi et al., 2014; Lian et al., 2005). Player position was dichotomized
by positions that require frequent episodes of jumping (e.g., OH, MB, OPP) or by
positions that require a lower frequency of vertical jumping (e.g., S, L, DS). Athletes in
the “jumping” group (e.g., OH, MB, OPP) were categorized as at risk; setters, liberos,
and defensive specialists served as the reference group. It was hypothesized that
athletes who perform more jumps during sport would be at a greater risk of having
a tendon abnormality. Starters were identified from season statistics as the players
who started a majority of games for their team. Starters were categorized as at risk
whereas non-starters served as the reference group. It was hypothesized that starters
may be at a greater risk because they may have more exposure (i.e., time spent on
the court during practices and games) than their non-starter counterparts. Athletes
were dichotomized into two groups based on the level of competition: NCAA D II
and NAIA athletes were categorized as at risk whereas NCAA D III athletes served as
the reference group. This dichotomization was made based on programmes that can
offer athletic scholarships (e.g., NCAA D II, NAIA) and those that cannot (NCAA D III).
Mean scores for off-season training habits were used to dichotomize athletes into at
risk and lesser risk groups. There is evidence that athletes who devote less time to
off-season training are at a greater risk for a noncontact time-loss injury (Brumitt
et al., 2017; Rauh, 2014).
Incidence density was calculated by dividing the number of cases of patellar tendino-
pathy resulting in time-loss from sport by the total number of athletic exposures (1 AE = 1
practice or 1 game). Relative risk was calculated to determine the risk of developing
patellar tendinopathy based on preseason presence of a patellar tendon abnormality
(Peers & Lysens, 2005). Open Epi was used to calculate the sample size. SPSS 25 was used
for all statistical calculations (Chicago, IL).
Results
Twenty-two subjects (20.8% of the population) presented with patellar tendon
abnormality (i.e., sonographic evidence of a hypoechoic region) in at least one
knee during preseason testing. Of the 212 tendons evaluated there were a total of
28 tendons (13.2% of all tendons) with an abnormality: 16 cases of a unilateral
presentation (eight cases of tendon abnormality on the right side, eight cases of
tendon abnormality on the left) and six individuals that had bilateral presentation
(n = 12). There was no difference in demographic measures, anthropometric
measures, or reported off-season training habits between those with tendon
abnormality and those without (Table 1; all p-values > 0.05).
The odds of presenting with a patellar tendon abnormality based on demo-
graphics, anthropometric measures, off-season training habits, and sport-specific
measures (e.g. player position, starter status, level of competition) are presented in
Table 2. There were no significant associations between the aforementioned char-
acteristics and the presence of tendon abnormality.
There were only two time-loss patellar tendinopathy cases that occurred during
the course of this study. A total of 7746 athletic exposures occurred during the
course of the study. The incidence density for time-loss patellar tendinopathy was
0.26 (95% CI: 0.04, 0.85) per 1000 AEs. Athletes who presented with a hypoechoic
region were no more likely to develop symptomatic patellar tendinopathy during
the season than athletes without tendon abnormality (relative risk = 1.0 [95% CI: 0.0,
20.4]; p-value = 0.516) (Table 3).
Table 1. Comparison of demographic information, anthropometric measures, and reported off-season
training habits between female collegiate volleyball players with patellar tendon abnormality (PTA) or







(n = 84) p-valueǂ
Age (y) 19.3 (1.1) 19.1 (1.0) 19.4 (1.1) 0.408
Years in School (y) 2.2 (1.1) 2.2 (1.1) 2.2 (1.1) 0.974
Age Starting Sport (y) 11.7 (2.2) 11.7 (2.1) 11.7 (2.2) 0.977
Off-Season Training Habits (hr./wk.):
Weight lifting 4.7 (2.9) 4.6 (3.5) 4.7 (2.8) 0.863
Plyometric training 2.5 (1.9) 2.1 (1.3) 2.6 (2.1) 0.294
Scrimmaging 3.9 (6.2) 3.8 (6.5) 4.0 (6.1) 0.898
Height (m) 1.74 (0.08) 1.74 (0.07) 1.74 (0.08) 0.925
Weight (kg) 71.2 (9.6) 71.9 (10.2) 71.0 (9.5) 0.702
Body Mass Index 23.5 (2.7) 23.6 (2.3) 23.5 (2.8) 0.825
aReported off-season training habits during the 6-week period prior to the start the official preseason.
ǂComparison between subjects with PTA versus subjects without PTA
Discussion
To our knowledge, this is the first study to report the prevalence of patellar tendon
abnormality and the incidence of time-loss patellar tendinopathy in female collegiate
volleyball players. The results of this study indicate that over 20% of athletes started the
season with a hypoechoic region in at least one of their patellar tendons. However, there
was no association between tendon abnormality and the potential risk factors explored in
this study. This study also presented the incidence of time-loss patellar tendinopathy. The
Table 2. Relationships between age, anthropometric measures, and sport-related demographics with
the presence of patellar tendon abnormality.






19 or younger 60 9 (15.0) Reference 0.792
20 or older 46 13 (28.3) 0.9 (0.3, 2.3)
Height (m)
1.73 or less 51 10 (19.6) Reference 0.779
1.74 or more 55 12 (21.8) 1.1 (0.4, 2.9)
Weight (kg)
71.19 kg or less 48 11 (22.9) Reference 0.618
71.20 kg or more 58 11 (19.0) 0.8 (0.3, 2.0)
BMI (kg/m2)
23.49 or less 50 10 (20.0) Reference 0.856
23.50 or more 56 12 (21.4) 1.1 (0.4, 2.8)
Position
S, L, DS 39 7 (17.8) Reference 0.587
OH, MB, OPP 67 15 (22.4) 1.3 (0.5, 3.6)
Starter Status
Non-Starter 66 13 (19.7) Reference 0.730
Starter 40 9 (22.5) 0.8 (0.3, 2.2)
Level of Competition§
NCAA DIII 49 13 (26.5) Reference 0.519
NCAA DII/NAIA 57 9 (15.8) 0.5 (0.2, 1.3)
Off-Season Training Habits (hr./wk.):
Weight lifting
4.7 hr. or more 47 9 (19.2) Reference 0.716
<4.7 hr. 59 13 (22.0) 1.2 (0.5, 3.1)
Plyometric training
2.5 hr. or more 36 6 (22.9) Reference 0.458
< 2.5 hr. 70 16 (16.7) 1.5 (0.5, 4.2)
Scrimmaging
3.9 hr. or more 34 7 (20.6) Reference 0.977
<3.9 hr. 72 15 (20.8) 1.0 (0.4, 2.7)
NCAA = National Collegiate Athletic Association; NAIA = National Association of Intercollegiate Athletics; D II = Division II;
D III = Division III
§ – Dichotomization based on competition levels eligible to offer athletic scholarships
Table 3. Relative risk of developing patellar tendinopathy based on the presence of patellar tendon
abnormality.
Category Subjects per category Cases of PT (%) Relative risk (95% CI) p-value
Patellar Tendon Abnormality
Yes 22 0 (0)a 1.0 (0.0, 20.4) 0.516
No 84 2 (2.4) Reference
aTo account for zero subjects 0.5 was entered into the 2 × 2 contingency table
presence of patellar tendon abnormality at the start of the preseason was not associated
with the onset of the condition during the season.
The first purpose of this study was to report the prevalence of patellar tendon
abnormality in a population of female collegiate volleyball players and to determine if
there are characteristics associated with a greater odds of presenting with patellar tendon
abnormality. The presence of a hypoechoic region represents a failed repair response to
loading (Cook, Khan, Kiss, Coleman, & Griffiths, 2001b; Kaux, Forthomme, Le Goff,
Crielaard, & Croisier, 2011; Ker, 2002; Malliaras, Cook, Ptasznik, & Thomas, 2006;
Shepherd & Screen, 2013). The prevalence of patellar tendon abnormality (20.8% of the
population) in this study is consistent, albeit a bit lower, with the proportions reported in
prior studies: 26% in elite teenage basketball players, 36% in elite junior volleyball players,
26.6% in adult volleyball players, and 33.7% in male collegiate basketball players (Cook
et al., 2000b; Gisslen et al., 2007; Keefer Hutchison et al., 2019; Malliaras et al., 2006). It is
important to recognize that the presence of a hypoechoic region does not mean that one
is symptomatic. In this study, the athletes were able to participate fully in sport and were
currently not under the care of a physician or an athletic trainer.
Associations between demographic information, training habits, anthropometric mea-
sures, or sports specific characteristics and the presence of patellar tendon abnormality
during the preseason were evaluated. None of the explored variables were associated
with a greater risk of presenting with a hypoechoic region in the patellar tendon. This
finding is consistent with a recent report that found no relationship between tendon
abnormality and demographic information, anthropometrics, player position, and com-
petition level in male collegiate basketball players (Keefer Hutchison et al., 2019).
However, in that study the authors reported non-starters were 3.5 times more likely to
present with ultrasonic evidence of tendon abnormality at the start of the preseason
(Keefer Hutchison et al., 2019).
The second purpose of this study was to report the incidence density of time-loss
patellar tendinopathy in a population of female collegiate VB players. The incidence of
patellar tendinopathy was higher than what was hypothesized [0.26 (95% CI: 0.04, 0.85)
per 1000 AEs]. This incidence rate is important and warrants discussion. First, the afore-
mentioned rate is higher than what has been previously reported. A prior multi-year
epidemiological study reported a rate of 0.15 patella or patella tendon injuries per 1000
AEs (during practices) and a rate of 0.10 patella or patella tendon injuries per 1000 AEs
(during games) (Agel et al., 2007). This rate included athletes from all levels of collegiate
competition and all diagnoses related to the patella. It is possible that athletes who
participate at higher levels of competition (e.g., NCAA Division I [none evaluated in this
study] and/or those who are competing for scholarship-granting programmes (e.g., NCAA
D II, NAIA) may be monitored or trained differently than athletes who compete at the
NCAA D III level. This is only speculative, but in this study, the two cases of patellar
tendinopathy were diagnosed in athletes from the NCAA D III level. Of the 22 athletes who
presented with a patellar tendon abnormality during testing a majority were from the
NCAA D III level: 13 (59.1%) were NCAA D III athletes, 5 (22.7%) were NCAA D II athletes,
and 4 (18.2%) were NAIA athletes. Second, because the incidence reported in this study
included a larger percentage of athletes from the NCAA D III level (46% of total popula-
tion) this rate should be viewed with caution. Future studies are warranted to identify
preseason prevalence rates for patellar tendon abnormality and in-season incidence rates
for patellar tendinopathy for individual levels of competition.
The third purpose of this study was to determine if preseason presence of patellar
tendon abnormality was associated with a greater risk of developing time-loss patellar
tendinopathy. In this study preseason presence of a hypoechoic region was not asso-
ciated with the onset of symptomatic patellar tendinopathy. As previously mentioned
Cook et al. (2000a) and Visnes et al. (2015) reported the presence of a patellar tendon
abnormality in the form a hypoechoic region in elite teenage athletes who were asymp-
tomatic was associated with a 3 to 4-fold increased risk of developing symptomatic
patellar tendinopathy. It is important to highlight that a thickened tendon is also an
abnormality observed on an ultrasound image; however, thickening of the tendon is
typically associated with symptomatic cases (Malliaras et al., 2015; Visnes et al., 2015). In
this study, a thickened tendon in conjunction with the presence of a hypoechoic region
was not evaluated as a potential risk factor. Visnes et al. (2015) previously reported that
a thickened tendon was not a risk factor in elite female VB players.
There are a few potential reasons for the difference between this study and prior
studies regarding tendon abnormality as a risk factor for the onset of symptomatic
patellar tendinopathy. First, the athletes evaluated in prior studies were younger than
the sample investigated in this study (Cook et al., 2000a; Visnes et al., 2015). It could be
speculated that younger athletes may be at a greater risk for symptomatic patellar
tendinopathy; however, the prevalence of this condition appears to be higher in adult
athletes (Cook et al., 2000b; Gisslen et al., 2007; Lian et al., 2005, 1996; Malliaras et al.,
2006). Rather, the greater incidence of patellar tendinopathy in Cook et al. (2000a) and
Visnes et al. (2015) when compared to the athletes in this study may be due to the
duration of their season. Elite teenage athletes (Cook et al., 2000a; Visnes et al., 2015) may
be at a greater risk of injury due to participating in a longer season than the approximately
4-month collegiate volleyball season in the United States. Second, there may be differ-
ences in injury rates between genders. This study only evaluated female volleyball players
whereas Cook et al. (2000a) assessed male and female basketball players and Visnes et al.
(2015) assessed male and female volleyball players. It is important to note that in both
studies the male players had a higher injury rate. Also, risk of patellar tendinopathy onset
was based on combining genders; it is possible that analysis of risk per gender may not
have been significant. It is important to note that this is only speculative and would
require future study. Third, the surveillance period differed between studies may have
been a factor. Cook et al. (2000a) followed the basketball players for a 16-month period
and Visnes et al. (2015) followed the VB players for a 4-year period. In this current study
athletes were only followed during the course of the 4-month season. The chance of
developing patellar tendinopathy may be greater in the aforementioned studies because
those athletes may have had more exposure (e.g., training sessions, total jumps per-
formed) than athletes in this current study. However, it is important to highlight that the
finding in this study is important for sports medicine professionals who work with VB at
the collegiate level in the United States. It would be inappropriate to apply the findings
from Cook et al. (2000a) or Visnes et al. (2015) to this population. Finally, even though we
recruited more athletes than our sample size calculation we may have been underpow-
ered due to the total cases occurring during the season.
There are several strengths to this study. First, diagnostic ultrasound images were
collected prospectively by experienced physiotherapists. Second, investigators collected
injury information and athletic exposures on a weekly basis to ensure accurate data
collection from each team. Third, several novel risk factors were evaluated to determine
if athletes were at a greater odds of presenting with a tendon abnormality based on
demographic factors, anthropometric measures, training habits, and sports specific char-
acteristics. Fourth, this study investigated prevalence of tendon abnormality and inci-
dence of patellar tendinopathy in a population that had not yet been investigated.
There are limitations associated with this study. First, as previously mentioned, this
study may have been underpowered to determine if preseason tendon abnormality is
associated with a greater risk of developing patellar tendinopathy. To address these
future investigations should evaluate athletes per level of competition and recruit
a larger sample size. Even though in this study we recruited more athletes than our
sample size calculation, that calculation was based on proportions from a study consisting
of teenage basketball players. Second, future investigations should consider monitoring
athletes over the course of several years. A relatively short 4-month surveillance period in
this study only produced two cases of patellar tendinopathy. Only two cases out of 106
athletes are a relatively small incidence of the disease; however, other studies have
recognized the prevalence of this condition to be as high as 50% (Lian et al., 1996).
Visnes et al. (2015) reported that the average time to disease onset was 0.9 years from the
start of the study. A future study assessing collegiate athletes in the United States should
evaluate all incoming freshmen following them for the course of their collegiate career.
Conclusion
The prevalence of patellar tendon abnormality in a population of female collegiate VB
players was greater than 20%; however, the incidence of patellar tendinopathy during the
season was low. The presence of tendon abnormality was not associated with an
increased risk of developing patellar tendinopathy; however, future studies are warranted
to prospectively evaluate potential risk factors over a longer surveillance period.
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